FDA Approves Booster Dose of Omicron-Specific Covid Vaccine For People Over 65

If new variants become dominant, this booster is the best protection.

Photo by CDC on Unsplash

On April 18, the FDA announced that individuals aged 65 and over, as well as those who are immunocompromised, are eligible to receive an additional dose of the bivalent formulations of the Moderna Covid-19 Vaccine and…